New implant could replace glaucoma drops after cataract surgery

NCT ID NCT06848946

Recruiting now Disease control Sponsor: Glaukos Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a tiny implant placed inside the eye during cataract surgery that slowly releases travoprost, a drug that lowers eye pressure. About 132 adults with glaucoma or high eye pressure will receive either the implant plus surgery or surgery alone. The goal is to see if the implant safely controls eye pressure better than surgery alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: travoprost intracameral implant
What this could lead to: If it works, this could offer a way to control eye pressure for months after cataract surgery without daily eye drops.
What could go wrong: This is a phase 4 trial with only 132 participants, so results may not apply to everyone. The implant could cause inflammation or fail to lower pressure enough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA, OPEN-ANGLE OCULAR HYPERTENSION (OHT) PHACOEMULSIFICATION CATARACT SURGERY

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Glaukos Investigator Site
RECRUITING

Kenosha, Wisconsin, 53142, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.